Photodynamic Therapy Market Forecast Highlights Expansion From $1.62 Billion To $2.04 Billion Through 2030

Global Photodynamic Therapy Market

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Photodynamic Therapy Market Growth Potential: How Will Market Size Change Through 2030?

The photodynamic therapy market has experienced robust expansion in recent years. Its value is projected to rise from $1.53 billion in 2025 to $1.62 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.1%. This historical growth has been driven by several factors, including a higher incidence of skin cancer and precancerous conditions, a growing preference for minimally invasive treatments, early-stage clinical confirmation of photosensitizers, increased public knowledge about non-surgical alternatives, and the widespread availability of laser-based medical equipment.

The market for photodynamic therapy is anticipated to experience substantial expansion over the coming years. By 2030, it is projected to reach a value of $2.04 billion, reflecting a compound annual growth rate (CAGR) of 5.9%. This forecasted growth is driven by innovations in new photosensitizer formulations, broader applications outside of oncology, a growing preference for outpatient procedures, heightened investments in cancer treatment facilities, and an increased focus on targeted and precision-based therapies. Key developments shaping this period involve the broader integration of photodynamic therapy in cancer care, its rising prominence in dermatology and cosmetic treatments, the creation of advanced photosensitizers, a trend toward less invasive cancer interventions, and the increasing adoption of combination treatment strategies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Photodynamic Therapy Market Expansion Drivers: What Is Shaping Future Growth?

The expansion of the photodynamic therapy market is being driven by the rising incidence of skin cancer. Skin cancer is identified as the most prevalent form of cancer among all types. Although melanoma makes up only about 1% of skin cancer cases, it is responsible for a significant proportion of skin cancer-related fatalities. Photodynamic therapy (PDT) involves using a light-sensitive drug combined with intense light exposure to eliminate cancer cells. A cream containing a light-sensitizing agent is applied by the physician to both the skin cancer lesion and the adjacent area. As an example, Cancer Australia, a governmental agency based in Australia, reported that in 2023, roughly 8,257 new diagnoses of skin melanoma were made, which represented 2.6% of all cancer deaths. Consequently, the growing prevalence of skin cancer is anticipated to boost the photodynamic therapy market in the years ahead.

Photodynamic Therapy Market Segment Outlook: Which Categories Are Expanding The Fastest?

The photodynamic therapy market covered in this report is segmented –

1) By Product: Drugs, Devices

2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications

3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations

2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

Photodynamic Therapy Market Strategic Trends: What Is Defining The Next Phase Of Growth?

Key players in the photodynamic therapy (PDT) market are placing significant emphasis on clinical research to examine the use of PDT alongside various medications, aiming to improve treatment results. Photodynamic therapy employs light-activated compounds to precisely target and eliminate cancerous or diseased cells. As an example, Kintara Therapeutics, a biotechnology firm headquartered in the US, launched a clinical trial in February 2024 for its REM-001 therapy, designed to treat cutaneous metastatic breast cancer (CMBC). This open-label study (NCT05374915) includes 15 participants and assesses a 0.8 mg dose of the second-generation PDT agent REM-001. The goal is to refine the trial design before proceeding to a Phase 3 study, with a focus on the Best Overall Objective Response Rate (bORR) over 24 weeks, utilizing primary endpoints that gauge both complete and partial reactions within the treated areas.

Photodynamic Therapy Market Key Companies And Competitive Benchmarking

Major companies operating in the photodynamic therapy market are Galderma S.A., Bausch Health, Lumenis Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Hologic Inc., Dusa Pharmaceuticals, PDT Pharma Indústria e Comércio de Produtos Farmacêuticos, MMOptics Ltd, Global Healthcare Solutions Perú, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc.

Access The Complete Photodynamic Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Photodynamic Therapy Market Global Footprint: Which Region Holds Market Leadership?

North America was the largest region in the photodynamic therapy market in 2025. The regions covered in the photodynamic therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model